Marty Chaplin
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
- Parasitology top 10%
- Parasites and Host Interactions
Papers in
-
- Tuberculosis Research and Epidemiology 3
- COVID-19 Clinical Research Studies 2
-
- Meta-analysis and systematic reviews 4
- Co-authors
- Tamara Kredo (2 shared papers)Bhagteshwar Singh (2 shared papers)Hannah Ryan (3 shared papers)Tom E. Fletcher (3 shared papers)Katherine Gleave (1 shared paper)Leslie Choi (1 shared paper)Natalie Lissenden (1 shared paper)Hilary Ranson (1 shared paper)
- Journals
- Cochrane Database of Systematic Reviews (23 papers)Health Technology Assessment (2 papers)BMC Cancer (1 paper)PLoS Medicine (1 paper)PharmacoEconomics - Open (4 papers)
- Partner nations
- United KingdomSouth AfricaSri Lanka
In The Last Decade
Marty Chaplin
31 papers receiving 801 citations
Peers
Comparison fields: 5 of 67
- Infectious Diseases 210
- Parasitology 39
- Public Health, Environmental and Occupational Health 130
- Clinical Biochemistry 12
- Pharmacology 18
Countries citing papers authored by Marty Chaplin
This map shows the geographic impact of Marty Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marty Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marty Chaplin more than expected).
Fields of papers citing papers by Marty Chaplin
This network shows the impact of papers produced by Marty Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marty Chaplin. The network helps show where Marty Chaplin may publish in the future.
Co-authors
The 25 scholars most cited alongside Marty Chaplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 144 | |
| 2 | 2021 | 97 | |
| 3 | 2020 | 63 | |
| 4 | 2019 | 62 | |
| 5 | 2022 | 61 | |
| 6 | 2021 | 60 | |
| 7 | 2022 | 58 | |
| 8 | 2019 | 38 | |
| 9 | 2020 | 37 | |
| 10 | 2021 | 29 | |
| 11 | 2022 | 27 | |
| 12 | 2024 | 20 | |
| 13 | 2021 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2019 | 15 | |
| 16 | 2021 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2023 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2019 | 7 |
About Marty Chaplin
Marty Chaplin is a scholar working on Infectious Diseases, Statistics, Probability and Uncertainty, Public Health, Environmental and Occupational Health, Complementary and alternative medicine and Clinical Biochemistry, having authored 34 papers that have together received 822 indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (4 papers), Malaria Research and Control (3 papers), Tuberculosis Research and Epidemiology (3 papers), Cardiovascular and exercise physiology (2 papers), COVID-19 Clinical Research Studies (2 papers), Yersinia bacterium, plague, ectoparasites research (2 papers), Mosquito-borne diseases and control (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Infectious Diseases (210 citations), Parasitology (39 citations), Public Health, Environmental and Occupational Health (130 citations), Clinical Biochemistry (12 citations) and Pharmacology (18 citations). Marty Chaplin has collaborated with scholars based in United Kingdom, South Africa and Sri Lanka. Frequent co-authors include Tamara Kredo, Bhagteshwar Singh, Hannah Ryan, Tom E. Fletcher, Katherine Gleave, Leslie Choi, Natalie Lissenden, Hilary Ranson, Angela Boland and Paul Garner. Their work appears in journals such as Cochrane Database of Systematic Reviews, Health Technology Assessment, BMC Cancer, PLoS Medicine and PharmacoEconomics - Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.